Octozi helps the pharma industry accelerate drug approvals with AI agents. Over $100 billion is spent on clinical development and thousands of hours of manual work goes into creating documentation, cleaning, and analyzing the data required for regulatory submission. Our AI-augmented platform automates processes involved in data cleaning and review, decreasing the time needed for database lock while enhancing data quality.
Location: United States
Total raised: $3M
Investors 1
| Date | Name | Website |
| - | Entreprene... | muratak.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.07.2026 | Seed | $3M | Remarkable... |
Mentions in press and media 5
| Date | Title | Description |
| 13.07.2026 | Octozi Secures $3M to Revolutionize Clinical Trial Data with Agentic AI | Octozi, a New York-based artificial intelligence company, recently secured $3 million in seed funding. This investment propels its agentic AI platform. The technology revolutionizes clinical trial data management. It automates crucial steps... |
| 11.07.2026 | Octozi Raises $3 Million Seed To Bring Agentic AI Into Clinical Trial Data Operations | Octozi, a New York City-based artificial intelligence company that automates clinical development workflows for pharmaceutical sponsors, has raised 3 million dollars in seed funding. Surface Ventures led the round, with participation from R... |
| 07.07.2026 | Octozi Raises $3M in Seed Funding to bring Agentic AI to Clinical Development | New York City, United States, July 7th, 2026, FinanceWire Octozi, an artificial intelligence company that automates clinical development workflows for pharmaceutical sponsors, has raised $3 million in seed funding. The round was led by Surf... |
| 22.08.2025 | DayOne Accelerator reveals latest cohort | The DayOne Accelerator is a three-month hybrid program for high-potential, early-stage techbio and healthtech ventures working at the intersection with Pharma R&D. Following the program revamp this year, the program coordinators are no... |
| - | Octozi | “Home | Octozi” |